Inhibikase Therapeutics, Inc. (IKT) — Shares Outstanding
| Fiscal Year | Shares Outstanding | Change YoY |
|---|---|---|
| 2025 | 131.69M | +89.9% |
| 2024 | 69.36M | +1021.2% |
| 2023 | 6.19M | +46.4% |
| 2022 | 4.22M | -83.2% |
| 2021 | 25.16M | +150.3% |
| 2020 | 10.05M | — |
| Fiscal Year | Shares Outstanding | Change YoY |
|---|---|---|
| 2025 | 131.69M | +89.9% |
| 2024 | 69.36M | +1021.2% |
| 2023 | 6.19M | +46.4% |
| 2022 | 4.22M | -83.2% |
| 2021 | 25.16M | +150.3% |
| 2020 | 10.05M | — |